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Abstract
The life cycle of human papillomaviruses (HPVs) is strictly linked to the
differentiation of their natural host cells. The HPV E6 and E7 oncoproteins
can delay the normal differentiation program of keratinocytes; however, the
exact  mechanisms  responsible  for  this  have  not  yet  been  identified.  The
goal of this study was to investigate the effects of HPV16 oncoproteins on
the  expression  of  genes  involved  in  keratinocyte  differentiation.  Primary
human  keratinocytes  transduced  by  LXSN (control)  retroviruses  or  virus
vectors expressing HPV16 E6, E7 or E6/E7 genes were subjected to gene
expression profiling. The results of microarray analysis showed that HPV
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16 E6 and E7 have the capacity to downregulate the expression of several
genes  involved  in  keratinocyte  differentiation.  Quantitative  real-time
polymerase  chain  reaction  (qRT-PCR)  assays  were  performed  to  confirm
the microarray data. To investigate the effects of the HPV oncoproteins on
the  promoters  of  selected  keratinocyte  differentiation  genes,  luciferase
reporter  assays were  performed.  Our  results  suggest  that  the  HPV 16 E6
and/or  E7  oncogenes  are  able  to  downregulate  the  expression  of  several
genes  involved  in  keratinocyte  differentiation  (such  as  desmocollin  1,
keratin 4, S100 calcium-binding protein A8 and small proline-rich protein
1A),  at  least  partially  by  downregulating  their  promoter  activity.  This
activity of the HPV oncoproteins may have a role in the productive virus
life cycle, and also in virus-induced carcinogenesis.
Electronic supplementary material
The online version of this article (doi:10.1007/s00705-014-2305-y) contains
supplementary material, which is available to authorized users.
Introduction
Certain types of human papillomaviruses (HPVs) (high-risk or oncogenic
types, such as HPV 16 and 18) are considered to be the causative agents of
cervical cancer [ 1 ]. The E6 and E7 early gene products are responsible for the
oncogenic potential of high-risk HPVs [ 2 ]. The transforming activity of E6
and E7 is mainly mediated through the inactivation of cellular tumour
suppressor proteins. High-risk HPV E6 is able to induce the functional
inactivation and proteosomal degradation of p53 [ 3 ]. The E7 proteins of
high-risk genital HPVs are able to bind to the retinoblastoma protein (Rb) and
to the related pocket proteins (p107 and p130), release E2F transcription
factors from the pocket proteins, and induce the progression of the cell cycle
[ 4 – 6 ]. The expression of the viral E6 and E7 proteins is indispensable for the
normal replication cycle of both low-risk and high-risk HPV types [ 7 ].
Genital HPVs replicate in stratified squamous epithelial tissues, especially in
the skin and mucous membranes of the genital area. The replication of the
virus genome and the expression of viral genes are strictly linked to the
differentiation of the keratinocyte host cell [ 8 , 9 ]. In the basal cells,
low-level viral genome replication takes place, along with the expression of
early genes, including the E6 and E7 oncogenes. High-level genome
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replication, expression of late genes and production of virions take place
exclusively in well-differentiated epithelial layers [ 10 ].
The expression of HPV E6 and E7 oncogenes has been shown to induce a
delay in the differentiation program of the host cell [ 11 – 13 ]. This is thought
to have a role in the productive viral replication cycle, where the virus has to
induce the cellular replication machinery in differentiating keratinocytes to
provide replication of the viral genome [ 7 , 9 , 10 ]. Inhibition of cellular
differentiation by high-risk HPVs is even more pronounced in premalignant
and malignant genital lesions, such as cervical intraepithelial neoplasia (CIN)
and cervical carcinoma. In these manifestations, a non-productive viral life
cycle takes place, with a lack of late gene expression and the absence of virion
production [ 10 , 14 ].
Gene expression profiling has revealed that cervical cancer samples compared
to normal cervical cells display reduced expression of several genes that are
involved in keratinocyte differentiation, such as involucrin (IVL), small
proline-rich proteins (SPRRs), S100A calcium-binding proteins and several
different keratin (KRT) proteins [ 15 , 16 ]. In accordance with this, studies
using in vitro cell culture model systems (primary human keratinocytes
transduced by recombinant retrovirus vectors) have revealed that the high-risk
HPV proteins E6 and/or E7 are able to downregulate the expression of these
differentiation-regulated genes [ 17 – 21 ]. However, there are few data on the
mechanisms by which the HPV oncogenes can regulate the expression of
keratinocyte differentiation genes. As these genes are known to be regulated
mainly at the level of transcription [ 22 ], it is reasonable to assume that the
HPV oncogenes might regulate the promoter activity of these cellular genes.
Indeed, we showed in a recent study that HPV 16 E6 and E7 caused strong
downregulation of the expression of involucrin (IVL) in human foreskin
keratinocytes and found E6 to downregulate the activity of the IVL promoter
[ 21 ].
In this study, we aimed to identify further keratinocyte differentiation genes
that are regulated by the HPV oncogenes at the transcriptional level. We
performed gene expression profiling in HPV-oncogene-transduced HFK cells
and confirmed that HPV 16 E6 and E7 have the ability to downregulate the
expression of several genes involved in keratinocyte differentiation.
Luciferase reporter assays were performed to investigate the effects of HPV
16 E6 and E7 oncoproteins on the transcriptional activities of selected genes
involved in keratinocyte differentiation.
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Materials and methods
Cell culture
Primary human foreskin keratinocytes (HFK) pooled from multiple neonatal
foreskins were obtained from Invitrogen (Carlsbad, CA, USA). The culture
and retroviral transduction of keratinocytes was described previously [ 21 ].
Briefly, HFK cells were cultured in Defined Keratinocyte-Serum Free
Medium (DK-SFM, Invitrogen) and infected with culture supernatants from
PA317 cell lines producing the control LXSN virus or LXSN-based retroviral
vectors expressing HPV16 E6, HPV16 E7 or HPV16 E6/E7 genes.
Microarray processing
Total RNA was isolated from each transduced keratinocyte cell line in three
biological replicates using an RNeasy Mini Kit (QIAGEN, Hilden, Germany).
RNA integrity was checked on an Agilent Bioanalyzer 2100 (Agilent
Technologies, Santa Clara, CA, USA). RNA samples with >9.0 RNA integrity
number (RIN) values were used in the further experiments. A NanoDrop
ND-1000 was used to determine RNA concentration. Global expression
patterns were analyzed on Affymetrix GeneChip Human Gene 1.0 ST arrays
(Affymetrix, Santa Clara, CA, USA). An Ambion WT Expression Kit
(Ambion, Austin, TX, USA) and a GeneChip WT Terminal Labeling and
Control Kit (Affymetrix) were used for amplifying and labeling 200 ng of
total RNA samples. Samples were hybridized at 45 °C for 16 hours, and a
standard washing protocol was then performed using an Affymetrix GeneChip
Fluidics Station 450. The arrays were scanned on a GeneChip Scanner 7G
(Affymetrix). RNA labelling and hybridization were carried out by
UD-GenoMed Medical Genomic Technologies Ltd (Debrecen, Hungary).
Microarray data analysis
Microarray data were analyzed using GeneSpring 12 GX software (Agilent
Technologies). Affymetrix CEL files were normalized using the Robust
Multichip Analysis (RMA) algorithm and median normalization. Expressed
genes were identified by filtering out the lowest 20 percentile of genes based
on raw signal intensity. Then, genes that did not show at least a twofold
difference compared to the median were also filtered out, and the remaining
3293 genes were called changing genes. Statistical analysis was performed on
the list of changing genes using a one-way ANOVA test with Tukey’s post hoc
test. Differences with p < 0.05 were considered statistically significant, and
e.Proofing http://eproofing.springer.com/journals/printpage.php?token=_-guYO...
4 / 22 2014.12.03. 11:03
the fold change cutoff value was 1.5. Pathway analysis was performed using
Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems). The
microarray data shown in this publication have been deposited in NCBI’s
Gene Expression Omnibus [ 23 ] and are accessible through GEO Series
accession number GSE58841 (http://www.ncbi.nlm.nih.gov/geo/query
/acc.cgi?acc=gse58841).
Quantitative real-time RT-PCR
The reverse transcription and real-time PCR reactions from retrovirus-
transduced HFKs were performed as described previously [ 21 ]. The assay IDs
of TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA,
USA) are shown in the appropriate figures and tables. Glyceraldehyde
3-phosphate dehydrogenase (GAPDH; 0711024) was used as an endogenous
control (Applied Biosystems). Each PCR reaction was performed in triplicate
at least three times. The comparative Ct method was used to obtain the
relative quantification (RQ) values with standard deviations (7500 System
SDS Software, version 1.4).
Plasmids
The Renilla luciferase reporter vectors containing the promoter regions of
KRT4 (S703756), KRT5 (S715429), SPRR1A (S703247), S100A8 (S703208)
and DSC1 (S701128) genes were obtained from SwitchGear Genomics
(Menlo Park, CA, USA). The pAP-1-Luc and pC/EBP-Luc plasmids
containing several copies of binding sites for AP-1 and C/EBP transcription
factors, respectively, were from Agilent Technologies. The pcDNA-based
constructs expressing HPV16 E6 or E7 were described previously [ 24 ].
Transient transfection and luciferase assay
The luciferase reporter assay is a simple and sensitive tool for studying the
transcriptional activities of viral or cellular gene promoters. Here, we used
this method to study the effects of HPV oncoproteins on the promoter
activities of cellular differentiation-associated genes in HFK cells
cotransfected with luciferase reporter vectors along with expression vectors
carrying the HPV oncogenes. Human foreskin keratinocytes (HFK) at
passages 3–5 were plated on 6-well plates at approximately 70–80 %
confluence. The HFK cells were transfected with 0.5 µg of reporter plasmids
containing the promoter region of selected differentiation-associated genes
(KRT4, KRT5, SPRR1A, S100A8 or DSC1) or reporter constructs containing
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multiple copies of AP-1 or C/EBPβ binding sites (pAP-1-Luc, pC/EBP-Luc),
along with 0.25 µg of expression vectors (pcDNA) encoding HPV 16 E6
and/or E7 genes using Effectene (QIAGEN) as described previously [ 21 ]. In
brief, transfection mix was added to cells in Opti-MEM (Invitrogen) and
incubated for 5 h at 37 °C, after which the medium was replaced by DK-SFM.
Forty-eight hours after transfection, the cells were washed twice with PBS
(phosphate-buffered saline) and lysed in Renilla Luciferase Assay Lysis
Buffer or Cell Cycle Lysis Reagent (Promega, Madison, WI, USA). The
luciferase activity of the cell extracts was measured using a Renilla Luciferase
Assay System or Luciferase Assay System (Promega) and a Berthold
luminometer. The Bradford protein assay was used to standardize for the
protein concentration of the cell extracts. The provider of the luciferase
reporter constructs (SwitchGear Genomics) did not recommend using
co-transfected reporter plasmids to standardize for transfection efficiency. To
analyse the results of luciferase tests, mean and SEM (standard error of mean)
of standardized luciferase values were calculated. Each transfection
experiment was performed independently at least three times. The statistical
significance of the difference between mean values was evaluated using the
ratio t-test (a paired t-test performed after logarithmic transformation of
standardized luciferase values).
Results
Global gene expression profiling of HFK cells transduced
by HPV 16 oncogenes
To explore the effects of HPV 16 E6 and E7 oncogenes on the global gene
expression profile of primary HFK cells, microarray analyses were performed
on low-passage HFK cells transduced by recombinant retroviruses.
Previously, we described the presence of HPV E6 and/or E7 mRNA in
transduced cells and their effect on the level of the cellular p53 oncoprotein
[ 21 ]. To further prove the presence of functionally active E6 and/or E7
proteins in the transduced cells, we first performed quantitative real-time
RT-PCR analysis of the expression of two selected cellular genes that are
known targets of E6 or E7 [ 25 , 26 ]. As expected, HPV 16 E6 strongly
induced the expression of the TERT (telomerase reverse transcriptase) gene,
while E7 increased the level of CDC25A (cell division cycle 25A) mRNA in
the transduced HFK cells (Fig. 1 ).
Fig. 1
The effect of HPV 16 E6, E7 oncogenes on the expression of CDC25A (A) and
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TERT (B) in human keratinocytes (HFK). Cells were transduced by retroviruses
carrying either the control vector (LXSN) or constructs encoding HPV16 E6, E7
or  E6/E7.  Relative  quantification  (RQ)  values  were  obtained  by  real-time
RT-PCR  analysis.  The  assay  IDs  of  TaqMan  gene  expression  assays  for
CDC25A and TERT were Hs00947994_m1, and Hs00972656_m1, respectively.
The RQ value of cells transduced by LXSN was set to 1, and other values are
shown relative to this. Each reaction was performed in triplicate at least three
times.  Representative  graphs  are  shown,  with  error  bars  indicating  standard
deviation. ** indicates significant (p < 0.01) gene expression difference relative
to LXSN
Using microarray analysis, we determined the global mRNA profile of three
independent sets of cells transduced by virus vectors carrying HPV 16 E6, E7,
or E6 and E7 genes compared to three sets of donor-matched cells transduced
by LXSN control vector (12 samples in total). Genes that were differentially
expressed under the four sets of conditions were identified by ANOVA test,
and unsupervised hierarchical clustering was then performed. The generated
heat map shows the separation between the conditions based on the ANOVA
result (Supplementary Fig. 1). The list of genes whose expression was
significantly altered by the HPV oncogenes (with a fold change of at least 1.5)
is shown in Supplementary Table 1. IPA analysis revealed that these
differentially expressed genes affect the regulation of cell cycle, cell death
and proliferation pathways/functions (Table 1 ). In accordance with the results
of previous studies using similar methodologies [ 17 – 20 ], we found that the
expression of several genes that are known to be involved in keratinocyte
differentiation (genes encoding involucrin (IVL), small proline-rich proteins
(SPRRs), S100A calcium-binding proteins and several different keratin (KRT)
proteins, among others) were significantly downregulated by the HPV
oncoproteins (Tables 1  and 2 ).
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Table 1
Functional analysis of differentially expressed genes
Cell cycle 2.22E−26 to2.30E−03 142 2
Cellular assembly
and organization
3.92E−22 to
2.07E−03 104 2
DNA replication,
recombination, and
repair
3.92E−22 to
2.33E−03 130 0
Cellular growth and
proliferation
1.49E−13 to
2.31E−03 174 7
Cell death and
survival
1.18E−12 to
2.02E−03 176 5
Functional characterization of differentially expressed genes was carried out with
the Ingenuity Pathway Analysis (IPA) software. The top five molecular and cellular
function categories are shown
Table 2
Fold  change  values  of  keratinocyte  differentiation  genes  whose  expression  was
significantly altered by HPV16 E6, E7 or E6/E7 oncogenes in microarray analysis
DSC1 Desmocollin 1 −1.19 −4.08 −2.64 0.014
DSG1 Desmoglein 1 1.32 −2.44 1.21 0.021
FLG Filaggrin 1.19 −2.39 −1.56 0.040
IVL Involucrin −1.60 −1.70 −2.53 0.004
KRT1 Keratin 1 1.04 −2.93 −1.50 0.035
KRT10 Keratin 10 1.26 −3.87 1.01 0.009
KRT13 Keratin 13 −1.25 −2.29 −1.70 0.031
KRT16 Keratin 16 −1.05 −1.74 1.06 0.044
KRT19 Keratin 19 −1.56 1.26 −1.90 0.012
Fold change (FC) values are shown relative to vector-control-transduced cells
(LXSN)
a
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Fold change (FC) values are shown relative to vector-control-transduced cells
(LXSN)
LCE2B Late cornified
envelope 2B −1.01 −1.75 −1.21 0.011
S100A8 S100 calcium-bindingprotein A8 −1.17 −1.26 −2.11 0.030
S100A9 S100 calcium-bindingprotein A9 −1.37 −1.43 −3.31 0.005
SPRR1A Small proline-richprotein 1A −1.15 −1.55 −1.97 0.021
SPRR1B Small proline-richprotein 1B −1.11 −1.25 −1.51 0.039
SPRR2A|SPRR2B Small proline-richprotein 2A small
proline-rich protein 2B
−1.87 −1.39 −2.81 0.031
SPRR3 Small proline-richprotein 3 −1.97 −4.06 −3.79 0.014
AQ1
Effect of HPV 16 oncogenesoncoproteins on endogenous
mRNA levels of selected keratinocyte differentiation genes
To validate gene expression data obtained by microarray analysis, we
performed quantitative real-time RT-PCR (qRT-PCR) assays on a subset of
genes involved in keratinocyte differentiation. Considering that real-time PCR
assays are known to have better sensitivity and reproducibility than
microarray analysis, we included in the RT-PCR analysis certain genes that
showed no change in expression in the microarray analysis but are known to
have a role in keratinocyte differentiation (such as CNFN, KRT4, LOR,
S100A10 and S100A12). As shown in Table 3 , most of the genes analysed
showed significantly decreased expression in the presence of the HPV 16 E6
and E7 oncogenes. Some of the genes investigated (such as KRT4 or
S100A12) were found to have significantly reduced expression in the presence
of the HPV oncoproteins in real-time RT-PCR analysis but not in microarray
analysis.
a
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Table 3
Relative quantification values of selected keratinocyte differentiation genes obtained by
quantitative real-time PCR analysis
CNFN Cornifelin Hs00261196_m1 1 ± 0.18 0.46 ± 0.03
DSC1 Desmocollin 1 Hs00245189_m1 1 ± 0.15 0.17 ± 0.01
DSG1 Desmoglein 1 Hs00170047_m1 1 ± 0.18 0.63 ± 0.03
IVL Involucrin Hs00846307_s1 1 ± 0.21 0.13 ± 0.02
KRT1 Keratin 1 Hs00196158_m1 1 ± 0.15 0.23 ± 0.01
KRT4 Keratin 4 Hs00361611_m1 1 ± 0.15 0.09 ± 0.01
KRT5 Keratin 5 Hs00361185_m1 1 ± 0.17 1.85 ± 0.18
KRT10 Keratin 10 Hs00166289_m1 1 ± 0.10 0.72 ± 0.04
LOR Loricrin Hs01894962_s1 1 ± 0.10 0.80 ± 0.03
NOTCH1 Notch homolog 1 Hs01062014_m1 1 ± 0.13 0.50 ± 0.03
SERPINB2
Serpin peptidase
inhibitor, clade B
(ovalbumin), member
2
Hs00234032_m1 1 ± 0.18 0.49 ± 0.02
SPRR1A Small proline-richprotein 1A Hs00954595_s1 1 ± 0.13 0.28 ± 0.01
SPRR1B Small proline-richprotein 1B Hs00234164_m1 1 ± 0.10 0.37 ± 0.03
S100A8 S100 calcium-bindingprotein A8 Hs00374264_g1 1 ± 0.12 0.13 ± 0.01
S100A9 S100 calcium-bindingprotein A9 Hs00610058_m1 1 ± 0.13 0.11 ± 0.01
S100A10 S100 calcium-bindingprotein A10 Hs00741221_m1 1 ± 0.12 0.79 ± 0.07
S100A12 S100 calcium-bindingprotein A12 Hs00942835_g1 1 ± 0.12 0.10 ± 0.01
Assay IDs identify the TaqMan gene expression assays (Applied Biosystems) used
for studying the gene expression changes of the indicated genes
RQ (relative quantification) values (with standard deviation) are shown relative to
vector-control-transduced cells (LXSN)
a
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Seven of the genes with altered expression in the presence of the HPV
oncoproteins (in microarray analysis and/or real-time RT-PCR assays) were
chosen for detailed gene expression analysis by real-time RT-PCR assays
(Fig. 2 ). For comparison, a basal keratin gene whose expression is known not
to be altered by differentiation (KRT5) was also included in the analysis. As
expected, KRT5 mRNA levels were not decreased by the HPV oncoproteins.
Rather, the HPV oncoproteins caused a 1.5- to 2-fold increase in the
expression of KRT5. On the other hand, the keratinocyte differentiation genes
analysed by real-time RT-PCR (DSC1, KRT1, KRT4, KRT10, S100A8,
S100A9 and SPRR1A) usually showed significantly decreased expression in
the presence of the HPV oncoproteins (Fig. 2 ). In a previous study, we also
found the expression of the human IVL (involucrin) gene to be downregulated
by HPV 16 oncoproteins [ 21 ]. Taken together, our results indicate that it may
be a general function of the HPV 16 E6 and E7 oncoproteins to downregulate
the expression of genes involved in the differentiation of stratified squamous
epithelial cells.
Fig. 2
Effect  of  HPV 16 oncogenes on the  endogenous mRNA level  of  DSC1 (A),
KRT1 (B), KRT4 (C), KRT10 (D), S100A8 (E), S100A9 (F), SPRR1A (G) and
KRT5 (H) in HFK cells. Generation of cell lines and estimation of RQ values
were  performed  as  described  in  the  legend  to  Fig.  1 .  Each  reaction  was
performed in triplicate at  least three times. Representative graphs are shown,
with  error  bars  indicating  standard  deviation.  Stars  indicate  significant  gene
expression differences relative to LXSN (*p < 0.05, **p < 0.01, ***p < 0.001)
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Effect of HPV 16 oncogenesoncoproteins on the promoter
activities of selected keratinocyte differentiation genes
To see the effects of the HPV oncogenes on the transcriptional activities of
keratinocyte differentiation genes whose expression has been analysed by
real-time RT-PCR assays, luciferase reporter assays were performed. These
experiments were conducted in HFK cells that were transiently co-transfected
with reporter vectors containing the promoters of different keratinocyte
differentiation genes (DSC1, KRT4, S100A8 and SPRR1A) along with HPV
16 E6, E7 or E6 and E7 expression vectors (Fig. 3 ). The promoter activities
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of each of these four genes were significantly decreased in cells transfected
with HPV 16 E6 and E7 oncogenes together (16E6E7) compared to cells
transfected with a control expression vector. As expected, the HPV
oncoproteins had little if any effect on the transcriptional activity of the KRT5
promoter (Fig. 3 E). Our results suggest that the downregulation of expression
by the HPV 16 oncoproteins of several genes involved in keratinocyte
differentiation is caused at least partly by inhibition of transcriptional
activities of these genes.
Fig. 3
Promoter  activity  of  DSC1  (A),  KRT4  (B),  S100A8  (C),  SPRR1A  (D)  and
KRT5 (E) in the presence of HPV 16 E6, E7 or both in human keratinocytes.
HFK cells were co-transfected with reporter plasmids containing the promoters
of  the  investigated  differentiation-associated  genes,  along with  either  control
vector (pcDNA) or expression constructs encoding HPV16 E6, E7 or both as
indicated. The Renilla luciferase activities are shown relative to the activity of
cells  transfected  with  reporter  plasmids  and  the  empty  expression  vector
(pcDNA). Data are from at least three independent experiments, with standard
errors  shown  as  error  bars.  Stars  indicate  the  significance  of  difference  in
transcriptional activity compared to control vector transfected cells (*p < 0.05,
**p < 0.01, ***p < 0.001)
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Effect of HPV 16 oncogenesoncoproteins on the activities of
AP-1 and C/EBP transcription factors
We presumed that the HPV 16 oncoproteins downregulate the expression of
keratinocyte differentiation genes by modifying the activities of certain
transcription factors. Sequence analysis of the promoters that were shown here
to be inhibited by the HPV oncoproteins revealed that each contains putative
binding sites for AP-1 (activator protein 1) and C/EBP (CCAAT enhancer
binding protein) transcription factor family members (Fig. 4 ). Therefore, we
decided to explore if the HPV 16 oncogenes have any effect on the activities
of these transcription factors. To this end, HFK cells were transfected with
luciferase reporter vectors containing multiple copies of binding sites for the
transcription factors AP-1 (jun/fos) or C/EBP along with HPV E6/E7
expression vectors. The results of luciferase tests showed that the HPV 16 E6
and E7 oncogenes together had a significant downregulating effect on both
C/EBP and AP-1 activity (Fig. 5 ). These results suggest that the
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downregulating effect of HPV 16 oncogenes on the promoters of certain
keratinocyte differentiation genes may be caused by inhibiting the activities of
transcription factors that are key regulators of these promoters, such as C/EBP
and AP-1 family members.
Fig. 4
Schematic  representation  of  SwitchGear  Genomics  reporter  constructs
containing  DSC1,  S100A8,  SPRR1A  and  KRT4  promoters  in  front  of  the
Renilla  luciferase  gene.  Selected  transcription  factor  recognition  sites  are
indicated  according  to  TFSEARCH  (www.cbrc.jp/research
/db/TFSEARCH.html)  and  the  JASPAR  database  (jaspar.genereg.net)  at
threshold score 80.0 (C/EBP-CCAAT enhancer binding protein)
Fig. 5
The effect of HPV oncogenes on the transcriptional activity of the C/EBP (A)
and AP-1  (B)  reporters  in  HFK cells.  Human keratinocytes  were  transfected
with  the  reporter  constructs,  along  with  either  control  vector  (pcDNA)  or
constructs  expressing  HPV16  E6,  E7  or  both  as  indicated.  The  luciferase
activity  of  cells  co-transfected  with  reporter  constructs  and  the  empty
expression vector (pcDNA) was set to 1, and the activities in other transfections
are relative to this. Results are from at least three independent experiments, with
standard errors shown as error bars. Stars indicate the significance of difference
in  transcriptional  activity  compared  to  control-vector-transfected  cells
(*p < 0.05, **p < 0.01)
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Discussion
In this study, we explored the effects of HPV 16 oncogenes on the expression
of cellular genes involved in keratinocyte differentiation by using microarray
analysis and quantitative real-time PCR assays. Microarray analysis is a
valuable method of global gene expression profiling that is capable of
measuring the expression levels of thousands of cellular genes. However, this
method has been shown to have relatively poor performance in demonstrating
expression changes of genes with low mRNA levels [ 27 ]. Also in this study,
some of the genes with altered expression by the HPV oncogenes (such as
CNFN, KRT4, LOR, S100A10 and S100A12) could be identified by real-time
PCR assays, but not by microarray analysis.
Most of the keratinocyte differentiation genes found here to be downregulated
by the HPV 16 oncogenes have already been shown to have reduced
expression in cervical cancer compared to normal cervical cells [ 15 , 16 ].
Accordingly, these genes have been shown to be downregulated by high-risk
HPV oncogenes by using in vitro cell culture model systems [ 17 – 21 ]. Thus,
it seems to be a general activity of high-risk HPV oncoproteins to
downregulate the expression of genes associated with keratinocyte
differentiation. This activity of HPV oncoproteins may have a role in the
productive viral life cycle [ 9 ]. The delay of host cell differentiation is also a
prominent feature of HPV-associated premalignant cervical lesions (CIN), and
it can be also seen in HPV-immortalized keratinocytes grown in organotypic
(raft) culture [ 28 – 30 ].
There are few data on the mechanism of action of the HPV oncogenes on the
expression of keratinocyte differentiation genes. In a previous study, we
showed that HPV 16 E6 downregulates the activity of the human IVL
promoter [ 21 ]. In this study, we went on to see the effects of HPV 16
oncogenes on the transcriptional activities of further differentiation-associated
genes (DSC1, KRT4, S100A8 and SPRR1A), which were shown to have
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reduced expression by the HPV oncoproteins in this study and also in
previous reports [ 17 – 20 ]. We found that the promoters of each of these genes
were usually downregulated by the HPV oncogenes. In each case, the
strongest effect was found when both HPV oncoproteins were expressed. It
may be speculated that the high-risk HPV E6 and E7 oncoproteins have an
additive or synergistic effect on the expression of keratinocyte differentiation
genes.
Usually, there was good correlation between the gene expression data
obtained by real-time RT-PCR and the promoter activity data obtained by
luciferase tests (compare Fig. 2  and 3 ). However, there were also examples
where the promoter activities did not correspond closely to the gene
expression data. For instance, HPV 16 E7 had no significant effect on the
S100A8 mRNA level (Fig. 2 E), while it had a significant downregulating
activity on S100A8 promoter activity (Fig. 3 C). On the other hand, HPV 16
E6 strongly decreased the SPRR1A mRNA level (Fig. 2 G), while it had no
significant effect on SPRR1A promoter activity (Fig. 3 D). These results may
indicate that, in addition to transcriptional regulation, other mechanisms (such
as post-transcriptional regulation) may contribute to the downregulation of
expression of these genes by the HPV oncoproteins. HPV 16 E6 has been
reported to induce the expression of the hTERT gene at the level of
transcription [ 3 ]. In addition, a cellular factor (NFX1-123) has been shown to
increase hTERT mRNA stability in the presence of HPV 16 E6. Thus,
transcriptional and posttranscriptional mechanisms seem to co-operate in the
regulation of expression of hTERT by HPV 16 E6. It is also conceivable that,
in addition to transcriptional regulation, posttranscriptional mechanisms (such
as regulation of RNA processing, transport or mRNA stability) also contribute
to the downregulation of expression of keratinocyte differentiation genes by
the HPV oncoproteins.
The HPV oncoproteins had no inhibitory effect on the promoter of KRT5,
which is a basal keratin gene, i.e., its expression is not regulated by
differentiation. Thus, it appears that the HPV 16 oncoproteins specifically
downregulate the transcription of keratinocyte genes whose expression is
regulated by differentiation. Taken together, our luciferase results indicate that
the HPV 16 oncogenes have a downregulating effect on the transcriptional
activities of several keratinocyte differentiation genes, and this mechanism
seems to contribute to the reduced expression of these genes in premalignant
and malignant cervical lesions compared to normal cervical epithelium [ 15 ,
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16 ].
We found that each of the promoters that were shown in this study to be
downregulated by the HPV oncoproteins have putative binding sites for AP-1
(jun/fos) and C/EBP transcription factors (Fig. 4 ). These transcription factors,
among others, have been shown to be significant in the transcriptional
regulation of keratinocyte differentiation genes and are themselves regulated
by epithelial differentiation [ 22 , 31 – 35 ]. Our experiments performed with
reporter constructs containing binding sites for these transcription factors
indicated that the HPV oncoproteins had significant inhibitory effects on the
activities of these transcription factors. Therefore, it is conceivable that the
HPV 16 oncoproteins downregulate certain keratinocyte differentiation
promoters by modifying the activities of AP-1 and C/EBP transcription
factors. In order to prove this scenario, further experiments would be needed,
including promoter mutagenesis and chromatin immunoprecipitation (ChIP)
assays.
In summary, gene expression analysis performed in this study in
HPV-oncogene-transduced HFK cells confirmed that HPV 16 E6 and E7
oncogenes downregulate the expression of several genes involved in
keratinocyte differentiation. Furthermore, luciferase reporter assays revealed
that the HPV 16 E6 and E7 oncoproteins were able to downregulate the
promoter activity of several of these genes. Our results suggest that the HPV
16 E6 and/or E7 oncogenes may have the potential to downregulate the
expression of several keratinocyte differentiation genes, at least partially by
downregulating their promoter activity. This activity of the HPV oncoproteins
may have a role in the productive virus life cycle, and also in virus-induced
carcinogenesis.
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